Southeast Regional Centers of Excellence for Biodefense & Emerging Infectious Di

东南区域生物防御卓越中心

• 批准号: 8105650
• 负责人: PHILIP Frederick SPARLING
• 金额: $ 49.92万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-26 至 2012-07-25
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8105650
• 关键词: Academia; Alabama; Alphavirus; Animal Model; Area; Bacteriology; Categories; Chikungunya virus; Commit; Complement; Dengue Virus; Diagnostic; Disease; Emergency Situation; Emerging Communicable Diseases; Encephalitis Viruses; Epitopes; Extreme drug resistant tuberculosis; Flavivirus; Florida; Francisella tularensis; Goals; Health; Immune response; Immune system; Immunology; Individual; Infection; Institution; Instruction; Intervention; Lead; Mission; Nature; North Carolina; Pathogenesis; Pathway interactions; Pharmaceutical Preparations; Prevention; Private Enterprises; Public Health; Research; Research Personnel; Research Training; Science; Scientist; Screening procedure; Sum; Technology; Therapeutic; Universities; Vaccines; West Nile virus; Work; base; biodefense; drug development; drug discovery; effective therapy; experience; innovation; member; multidisciplinary; novel vaccines; pathogen; programs; response; therapeutic vaccine; vaccine development; virology

PROJECT SUMMARY (See instructions): The Region IV Southeast Regional Center of Excellence for Emerging Infections and Biodefense (SERCEB) consists of six member institutions and 15 affiliate institutions across the Southeast. The University of North Carolina at Chapel Hill is the lead institution, with member institutions including the Duke University, Emory University, Vanderbilt University, the University of Alabama at Birmingham and the University of Florida- Gainesville. The goals of SERCEB are to develop new vaccines, therapeutics and diagnostics to better protect the nation against potential bioterrorist and emerging infectious disease threats. This is accomplished through interdisciplinary and collaborative research using cutting-edge science and technologies. SERCEB brings new investigators to the biodefense effort through a combination of educational programs, support of innovative new projects, and the synergistic interactions among its world-class investigators.

项目摘要（请参阅说明）： 东南地区IV区域卓越新兴感染和生物形式卓越中心（SERCEB）由六个成员机构和15个会员机构组成。北卡罗来纳大学教堂山分校是领导机构，其中包括杜克大学，埃默里大学，范德比尔特大学，阿拉巴马大学伯明翰大学和佛罗里达大学 - 盖恩斯维尔。 SERCEB的目标是开发新的疫苗，治疗学和诊断，以更好地保护国家免受潜在的生物恐怖主义和新兴的传染病威胁。这是通过使用尖端的科学和技术的跨学科和协作研究来实现的。 SERCEB通过教育计划的结合，将新的调查人员带入生物陷入困境的努力，支持 创新的新项目以及其世界一流调查人员之间的协同互动。